AviGenics

AviGenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases, and autoimmune diseases. AviGenics' proprietary technology generates therapeutic proteins with human-like glycosylation, enabling well-tolerated products with longer half-lives and higher clinical efficacy. Using this technology, the company has demonstrated that it can achieve commercially viable levels of therapeutic protein production and purification.